Natera, Inc.
NTRANatera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
Drugs in Pipeline
4
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How NTRA's past catalysts played out
Elacestrant
ER-positive Breast Cancer
mFOLFOX6 3-6 month
Stage III Colon Cancer
Folfirinox
Colorectal Cancer
Discontinuation of the anti-HER2 maintenance therapy
Metastatic Breast Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Elacestrant | Phase 3 | ER-positive Breast Cancer | - | - |
mFOLFOX6 3-6 month | Phase 3 | Stage III Colon Cancer | - | - |
Folfirinox | Phase 3 | Colorectal Cancer | - | - |
Discontinuation of the anti-HER2 maintenance therapy | Phase 2 | Metastatic Breast Cancer | - | - |
Frequently asked questions
What is in Natera, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Natera, Inc.'s (NTRA) pipeline across Phase 3, Phase 2. Its lead program is Elacestrant (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Natera, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Natera, Inc. (NTRA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NTRA biotech catalysts?→
Add NTRA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Natera, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.